These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29724202)

  • 41. Intracellular replication inhibitory effects of Galla Rhois ethanol extract for Brucella abortus infection.
    Lee JJ; Bae JH; Kim DH; Lim JJ; Kim DG; Lee HJ; Min W; Rhee MH; Chang HH; Park H; Kim S
    J Ethnopharmacol; 2011 Nov; 138(2):602-9. PubMed ID: 22008879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modelling the immunopathophysiology of Brucella melitensis and its lipopolysaccharide in mice infected via oral route of exposure.
    Osman AY; Kadir AA; Jesse FF; Saharee AA
    Microb Pathog; 2019 Nov; 136():103669. PubMed ID: 31445124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis.
    Shasha B; Lang R; Rubinstein E
    J Antimicrob Chemother; 1994 Mar; 33(3):545-51. PubMed ID: 8040118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brucella melitensis prosthetic joint infection in a traveller returning to the UK from Thailand: Case report and review of the literature.
    Lewis JM; Folb J; Kalra S; Squire SB; Taegtmeyer M; Beeching NJ
    Travel Med Infect Dis; 2016; 14(5):444-450. PubMed ID: 27591088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biotypes and antimicrobial susceptibilities of Brucella isolates.
    Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
    Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2015 Oct; 33(42):5532-5538. PubMed ID: 26384448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of resveratrol on shedding and pathological dynamics in experimental
    Tanko PN; Mohd Yusoff S; Emikpe BO; Bejo SK; Salisi S
    J Immunoassay Immunochem; 2019; 40(4):419-438. PubMed ID: 31154897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
    Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
    World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro drug resistance of clinical isolated Brucella against antimicrobial agents.
    Xu XL; Chen X; Yang PH; Liu JY; Hao XK
    Asian Pac J Trop Med; 2013 Nov; 6(11):921-4. PubMed ID: 24083592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X; Walters N; Robison A; Trunkle T; Pascual DW
    Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
    Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
    Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of long-term ethanol feeding on Brucella melitensis infection of rats.
    Yumuk Z; Ozdemirci S; Erden BF; Dundar V
    Alcohol Alcohol; 2001; 36(4):314-7. PubMed ID: 11468131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of immunopathophysiological responses induced by B. melitensis and its lipopolysaccharide in mouse model infected via intranasal route of exposure.
    Osman AY; Saharee AA; Jesse FF; Kadir AA
    Microb Pathog; 2017 Sep; 110():365-374. PubMed ID: 28710016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M.
    Motaharinia Y; Rezaee MA; Rashidi A; Jalili A; Rezaie MJ; Shapouri R; Hossieni W; Rahmani MR
    J Microbiol Immunol Infect; 2013 Aug; 46(4):253-8. PubMed ID: 22727892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
    Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.